ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$274.50
Tradestie Score
63
Market Cap
$12.36B
P/E Ratio
31.3
Revenue Growth
1.4%
Analyst Upside
+6.7%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$97.55
|
$24.57B | - | 56 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.52
|
$19.56B | 20.9 | 63 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.86
|
$16.93B | 16.1 | 61 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.77
|
$15.70B | 29.4 | 63 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.42
|
$15.22B | - | 49 | Compare |
|
EXEL
Exelixis Inc
|
$55.85
|
$11.09B | 17.9 | 63 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.13
|
$10.76B | - | 59 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$79.76
|
$10.74B | - | 58 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.99
|
$10.53B | 41.6 | 63 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$81.80
|
$10.49B | - | 64 | Compare |
More ASND Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry